MicroRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
Ontology highlight
ABSTRACT: Bladder cancer (BC) is the most frequent malignancy of the urinary tract with a high incidence in men and smokers. Currently, there are no non-invasive markers useful for BC diagnosis and subtypes classification that could overcome invasive procedures such as cystoscopy. Dysregulated miRNA profiles have been associated with numerous cancers, including BC. Cell-free miRNAs are abundantly present in a variety of biofluids including urine and make them promising candidates in cancer biomarker discovery. In the present study, the identification of miRNA fingerprints associated with different BC status was performed by next-generation sequencing on urine samples from 66 BC and 48 controls. Three signatures based on dysregulated miRNAs have been identified by regression models, assessing the pow
SUBMITTER: Pardini B
PROVIDER: S-EPMC5945522 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA